TILT Biotherapeutics closes €22M financing for oncology immunotherapy trials
TILT Biotherapeutics (TILT), a clinical-stage biotechnology company developing cancer immunotherapies, has closed its €22 million…
February 9, 2023 - 2 minutes
TILT Biotherapeutics
TILT and MSD working on immunotherapy trial for non-small cell lung cancer
TILT Biotherapeutics, a clinical-stage biotechnology company developing cancer immunotherapies, has signed a second clinical trial…
September 26, 2022 - 3 minutes
